0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiopulmonary Autotransfusion System Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-17107
Home | Market Reports | Health | Medical Facilities & Services | Medical Procedures
Global Cardiopulmonary Autotransfusion System Market Insights and Forecast to 2028

Global Cardiopulmonary Autotransfusion System Market Insights and Forecast to 2028

Code: QYRE-Auto-17107
Report
January 2022
Pages:92
QYResearch
Description
Table of Content
Tables & Figures
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
Market Analysis and Insights: Global Cardiopulmonary Autotransfusion System Market

Due to the COVID-19 pandemic, the global Cardiopulmonary Autotransfusion System market size is estimated to be worth US$ 567.4 million in 2022 and is forecast to a readjusted size of US$ 654.2 million by 2028 with a CAGR of 2.4% during the review period.

Fully considering the economic change by this health crisis, Unwashed ATS accounting for % of the Cardiopulmonary Autotransfusion System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Heart Surgery segment is altered to an % CAGR throughout this forecast period.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
Global Cardiopulmonary Autotransfusion System Scope and Segment
Cardiopulmonary Autotransfusion System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cardiopulmonary Autotransfusion System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Unwashed ATS
Washed ATS

Segment by Application

Heart Surgery
Great Organ Transplant Surgery
Other Surgery

BY COMPANY

Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Cardiopulmonary Autotransfusion System Product Introduction
1.2 Market by Type
1.2.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Unwashed ATS
1.2.3 Washed ATS
1.3 Market by Application
1.3.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Other Surgery
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cardiopulmonary Autotransfusion System Sales Estimates and Forecasts 2017-2028
2.2 Global Cardiopulmonary Autotransfusion System Revenue Estimates and Forecasts 2017-2028
2.3 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cardiopulmonary Autotransfusion System Sales by Region
2.4.1 Global Cardiopulmonary Autotransfusion System Sales by Region (2017-2022)
2.4.2 Global Sales Cardiopulmonary Autotransfusion System by Region (2023-2028)
2.5 Global Cardiopulmonary Autotransfusion System Revenue by Region
2.5.1 Global Cardiopulmonary Autotransfusion System Revenue by Region (2017-2022)
2.5.2 Global Cardiopulmonary Autotransfusion System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cardiopulmonary Autotransfusion System Sales by Manufacturers
3.1.1 Global Top Cardiopulmonary Autotransfusion System Manufacturers by Sales (2017-2022)
3.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cardiopulmonary Autotransfusion System in 2021
3.2 Global Cardiopulmonary Autotransfusion System Revenue by Manufacturers
3.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Manufacturers (2017-2022)
3.2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cardiopulmonary Autotransfusion System Revenue in 2021
3.3 Global Cardiopulmonary Autotransfusion System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cardiopulmonary Autotransfusion System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cardiopulmonary Autotransfusion System Sales by Type
4.1.1 Global Cardiopulmonary Autotransfusion System Historical Sales by Type (2017-2022)
4.1.2 Global Cardiopulmonary Autotransfusion System Forecasted Sales by Type (2023-2028)
4.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)
4.2 Global Cardiopulmonary Autotransfusion System Revenue by Type
4.2.1 Global Cardiopulmonary Autotransfusion System Historical Revenue by Type (2017-2022)
4.2.2 Global Cardiopulmonary Autotransfusion System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)
4.3 Global Cardiopulmonary Autotransfusion System Price by Type
4.3.1 Global Cardiopulmonary Autotransfusion System Price by Type (2017-2022)
4.3.2 Global Cardiopulmonary Autotransfusion System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cardiopulmonary Autotransfusion System Sales by Application
5.1.1 Global Cardiopulmonary Autotransfusion System Historical Sales by Application (2017-2022)
5.1.2 Global Cardiopulmonary Autotransfusion System Forecasted Sales by Application (2023-2028)
5.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)
5.2 Global Cardiopulmonary Autotransfusion System Revenue by Application
5.2.1 Global Cardiopulmonary Autotransfusion System Historical Revenue by Application (2017-2022)
5.2.2 Global Cardiopulmonary Autotransfusion System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)
5.3 Global Cardiopulmonary Autotransfusion System Price by Application
5.3.1 Global Cardiopulmonary Autotransfusion System Price by Application (2017-2022)
5.3.2 Global Cardiopulmonary Autotransfusion System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cardiopulmonary Autotransfusion System Market Size by Type
6.1.1 North America Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)
6.1.2 North America Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)
6.2 North America Cardiopulmonary Autotransfusion System Market Size by Application
6.2.1 North America Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)
6.2.2 North America Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)
6.3 North America Cardiopulmonary Autotransfusion System Market Size by Country
6.3.1 North America Cardiopulmonary Autotransfusion System Sales by Country (2017-2028)
6.3.2 North America Cardiopulmonary Autotransfusion System Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cardiopulmonary Autotransfusion System Market Size by Type
7.1.1 Europe Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)
7.1.2 Europe Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)
7.2 Europe Cardiopulmonary Autotransfusion System Market Size by Application
7.2.1 Europe Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)
7.2.2 Europe Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)
7.3 Europe Cardiopulmonary Autotransfusion System Market Size by Country
7.3.1 Europe Cardiopulmonary Autotransfusion System Sales by Country (2017-2028)
7.3.2 Europe Cardiopulmonary Autotransfusion System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Type
8.1.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)
8.1.2 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)
8.2 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Application
8.2.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)
8.2.2 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)
8.3 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Region
8.3.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2017-2028)
8.3.2 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Cardiopulmonary Autotransfusion System Market Size by Type
9.1.1 Latin America Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)
9.1.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)
9.2 Latin America Cardiopulmonary Autotransfusion System Market Size by Application
9.2.1 Latin America Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)
9.2.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)
9.3 Latin America Cardiopulmonary Autotransfusion System Market Size by Country
9.3.1 Latin America Cardiopulmonary Autotransfusion System Sales by Country (2017-2028)
9.3.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Type
10.1.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)
10.2 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Application
10.2.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)
10.3 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country
10.3.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Haemonetics
11.1.1 Haemonetics Corporation Information
11.1.2 Haemonetics Overview
11.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Haemonetics Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Overview
11.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medtronic Recent Developments
11.3 LivaNova
11.3.1 LivaNova Corporation Information
11.3.2 LivaNova Overview
11.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 LivaNova Recent Developments
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Corporation Information
11.4.2 Fresenius Kabi Overview
11.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Fresenius Kabi Recent Developments
11.5 Terumo
11.5.1 Terumo Corporation Information
11.5.2 Terumo Overview
11.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Terumo Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Terumo Recent Developments
11.6 Wandong Health Sources
11.6.1 Wandong Health Sources Corporation Information
11.6.2 Wandong Health Sources Overview
11.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Wandong Health Sources Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cardiopulmonary Autotransfusion System Industry Chain Analysis
12.2 Cardiopulmonary Autotransfusion System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cardiopulmonary Autotransfusion System Production Mode & Process
12.4 Cardiopulmonary Autotransfusion System Sales and Marketing
12.4.1 Cardiopulmonary Autotransfusion System Sales Channels
12.4.2 Cardiopulmonary Autotransfusion System Distributors
12.5 Cardiopulmonary Autotransfusion System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cardiopulmonary Autotransfusion System Industry Trends
13.2 Cardiopulmonary Autotransfusion System Market Drivers
13.3 Cardiopulmonary Autotransfusion System Market Challenges
13.4 Cardiopulmonary Autotransfusion System Market Restraints
14 Key Findings in The Global Cardiopulmonary Autotransfusion System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Unwashed ATS
    Table 3. Major Manufacturers of Washed ATS
    Table 4. Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Cardiopulmonary Autotransfusion System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Cardiopulmonary Autotransfusion System Sales by Region (2017-2022) & (Units)
    Table 7. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2017-2022)
    Table 8. Global Cardiopulmonary Autotransfusion System Sales by Region (2023-2028) & (Units)
    Table 9. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2023-2028)
    Table 10. Global Cardiopulmonary Autotransfusion System Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2017-2022)
    Table 12. Global Cardiopulmonary Autotransfusion System Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2023-2028)
    Table 14. Global Cardiopulmonary Autotransfusion System Sales by Manufacturers (2017-2022) & (Units)
    Table 15. Global Cardiopulmonary Autotransfusion System Sales Share by Manufacturers (2017-2022)
    Table 16. Global Cardiopulmonary Autotransfusion System Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers (2017-2022)
    Table 18. Cardiopulmonary Autotransfusion System Price by Manufacturers (2017-2022) &(K US$/Unit)
    Table 19. Global Cardiopulmonary Autotransfusion System Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Cardiopulmonary Autotransfusion System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion System as of 2021)
    Table 21. Cardiopulmonary Autotransfusion System Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Cardiopulmonary Autotransfusion System Product Offered
    Table 23. Date of Manufacturers Enter into Cardiopulmonary Autotransfusion System Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)
    Table 26. Global Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)
    Table 27. Global Cardiopulmonary Autotransfusion System Sales Share by Type (2017-2022)
    Table 28. Global Cardiopulmonary Autotransfusion System Sales Share by Type (2023-2028)
    Table 29. Global Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Cardiopulmonary Autotransfusion System Revenue Share by Type (2017-2022)
    Table 32. Global Cardiopulmonary Autotransfusion System Revenue Share by Type (2023-2028)
    Table 33. Cardiopulmonary Autotransfusion System Price by Type (2017-2022) & (K US$/Unit)
    Table 34. Global Cardiopulmonary Autotransfusion System Price Forecast by Type (2023-2028) & (K US$/Unit)
    Table 35. Global Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)
    Table 36. Global Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)
    Table 37. Global Cardiopulmonary Autotransfusion System Sales Share by Application (2017-2022)
    Table 38. Global Cardiopulmonary Autotransfusion System Sales Share by Application (2023-2028)
    Table 39. Global Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Cardiopulmonary Autotransfusion System Revenue Share by Application (2017-2022)
    Table 42. Global Cardiopulmonary Autotransfusion System Revenue Share by Application (2023-2028)
    Table 43. Cardiopulmonary Autotransfusion System Price by Application (2017-2022) & (K US$/Unit)
    Table 44. Global Cardiopulmonary Autotransfusion System Price Forecast by Application (2023-2028) & (K US$/Unit)
    Table 45. North America Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)
    Table 46. North America Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)
    Table 47. North America Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)
    Table 50. North America Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)
    Table 51. North America Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Cardiopulmonary Autotransfusion System Sales by Country (2017-2022) & (Units)
    Table 54. North America Cardiopulmonary Autotransfusion System Sales by Country (2023-2028) & (Units)
    Table 55. North America Cardiopulmonary Autotransfusion System Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Cardiopulmonary Autotransfusion System Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)
    Table 58. Europe Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)
    Table 59. Europe Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)
    Table 62. Europe Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)
    Table 63. Europe Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Cardiopulmonary Autotransfusion System Sales by Country (2017-2022) & (Units)
    Table 66. Europe Cardiopulmonary Autotransfusion System Sales by Country (2023-2028) & (Units)
    Table 67. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)
    Table 70. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)
    Table 71. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)
    Table 74. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)
    Table 75. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2017-2022) & (Units)
    Table 78. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2023-2028) & (Units)
    Table 79. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)
    Table 82. Latin America Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)
    Table 83. Latin America Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)
    Table 86. Latin America Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)
    Table 87. Latin America Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2017-2022) & (Units)
    Table 90. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2023-2028) & (Units)
    Table 91. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)
    Table 94. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)
    Table 95. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)
    Table 98. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)
    Table 99. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2017-2022) & (Units)
    Table 102. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2023-2028) & (Units)
    Table 103. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Haemonetics Corporation Information
    Table 106. Haemonetics Description and Major Businesses
    Table 107. Haemonetics Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)
    Table 108. Haemonetics Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Haemonetics Recent Developments
    Table 110. Medtronic Corporation Information
    Table 111. Medtronic Description and Major Businesses
    Table 112. Medtronic Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)
    Table 113. Medtronic Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Medtronic Recent Developments
    Table 115. LivaNova Corporation Information
    Table 116. LivaNova Description and Major Businesses
    Table 117. LivaNova Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)
    Table 118. LivaNova Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. LivaNova Recent Developments
    Table 120. Fresenius Kabi Corporation Information
    Table 121. Fresenius Kabi Description and Major Businesses
    Table 122. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)
    Table 123. Fresenius Kabi Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Fresenius Kabi Recent Developments
    Table 125. Terumo Corporation Information
    Table 126. Terumo Description and Major Businesses
    Table 127. Terumo Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)
    Table 128. Terumo Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Terumo Recent Developments
    Table 130. Wandong Health Sources Corporation Information
    Table 131. Wandong Health Sources Description and Major Businesses
    Table 132. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)
    Table 133. Wandong Health Sources Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Wandong Health Sources Recent Developments
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Cardiopulmonary Autotransfusion System Distributors List
    Table 138. Cardiopulmonary Autotransfusion System Customers List
    Table 139. Cardiopulmonary Autotransfusion System Market Trends
    Table 140. Cardiopulmonary Autotransfusion System Market Drivers
    Table 141. Cardiopulmonary Autotransfusion System Market Challenges
    Table 142. Cardiopulmonary Autotransfusion System Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cardiopulmonary Autotransfusion System Product Picture
    Figure 3. Global Cardiopulmonary Autotransfusion System Market Share by Type in 2021 & 2028
    Figure 3. Unwashed ATS Product Picture
    Figure 4. Washed ATS Product Picture
    Figure 5. Global Cardiopulmonary Autotransfusion System Market Share by Application in 2021 & 2028
    Figure 6. Heart Surgery
    Figure 7. Great Organ Transplant Surgery
    Figure 8. Other Surgery
    Figure 9. Cardiopulmonary Autotransfusion System Report Years Considered
    Figure 10. Global Cardiopulmonary Autotransfusion System Sales 2017-2028 (Units)
    Figure 11. Global Cardiopulmonary Autotransfusion System Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Cardiopulmonary Autotransfusion System Revenue 2017-2028 (US$ Million)
    Figure 13. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2017-2022)
    Figure 15. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2023-2028)
    Figure 16. North America Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)
    Figure 17. North America Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)
    Figure 19. Europe Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)
    Figure 21. Asia-Pacific Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)
    Figure 23. Latin America Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)
    Figure 25. Middle East & Africa Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Cardiopulmonary Autotransfusion System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Cardiopulmonary Autotransfusion System in the World: Market Share by Cardiopulmonary Autotransfusion System Revenue in 2021
    Figure 28. Global Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)
    Figure 30. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)
    Figure 31. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)
    Figure 32. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)
    Figure 33. North America Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)
    Figure 34. North America Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)
    Figure 35. North America Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)
    Figure 36. North America Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)
    Figure 37. North America Cardiopulmonary Autotransfusion System Sales Share by Country (2017-2028)
    Figure 38. North America Cardiopulmonary Autotransfusion System Revenue Share by Country (2017-2028)
    Figure 39. U.S. Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)
    Figure 42. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)
    Figure 44. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Cardiopulmonary Autotransfusion System Sales Share by Country (2017-2028)
    Figure 46. Europe Cardiopulmonary Autotransfusion System Revenue Share by Country (2017-2028)
    Figure 47. Germany Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 48. France Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Cardiopulmonary Autotransfusion System Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Share by Region (2017-2028)
    Figure 58. China Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 61. India Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Cardiopulmonary Autotransfusion System Sales Share by Country (2017-2028)
    Figure 72. Latin America Cardiopulmonary Autotransfusion System Revenue Share by Country (2017-2028)
    Figure 73. Mexico Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Share by Country (2017-2028)
    Figure 82. Turkey Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)
    Figure 85. Cardiopulmonary Autotransfusion System Value Chain
    Figure 86. Cardiopulmonary Autotransfusion System Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Prothrombin Complex Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35S2022
Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Localization for Breast Surgery Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-12L6122
Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Absorbable Bone Nail Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4T5575
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Enzymatic Debridement Ointment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34J5857
Sun May 19 00:00:00 UTC 2024

Add to Cart